← FDA DRUG APPROVALS

FDA ANDA · ANDA077174

FOSCARNET SODIUM

Sponsor: HOSPIRA

APPLICATION
ANDA077174
TYPE
ANDA
ORIGINAL APPROVAL
2005-05-31
LATEST ACTION
2008-05-09
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

FOSCARNET SODIUMDiscontinued
FOSCARNET SODIUM 6GM/250ML (24MG/ML) · SOLUTION · INTRAVENOUS
FOSCARNET SODIUMDiscontinued
FOSCARNET SODIUM 12GM/500ML (24MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2008-05-09Labeling · Supplement 4AP
2005-05-31Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →